Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D8UZ5R
|
|||
| Drug Name |
NBF-006
|
|||
| Drug Type |
Small interfering RNA
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Phase 1 | [1] | |
| Non-small-cell lung cancer [ICD-11: 2C25.Y; ICD-9: 162] | Phase 1 | [1] | ||
| Pancreatic cancer [ICD-11: 2C10; ICD-9: 157] | Phase 1 | [1] | ||
| Company |
Nitto Biopharma
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | GSTP1 messenger RNA (GSTP1 mRNA) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03819387) A Study of NBF-006 in Non-Small Cell Lung, Pancreatic, or Colorectal Cancer. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Nitto Biopharma. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.